Vancouver, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life”, “Juva” or “Company”), A life sciences company with a consumer business in pharmaceutical research and development and cannabis production and distribution today announced the completion of the final stages of construction at its 30,000-square-foot cannabis plant in Stockton, California. ..
“If this expansion is completed successfully, the capacity of the Stockton cultivation facility will be effectively doubled,” said Doug Chloupek, CEO and founder of Juva. “We thank the hard-working team for helping us successfully complete the expansion of this facility and are excited to see the increased revenue it generates. Treating health effects such as inflammation of the human body. As we continue our path to identify potential pharmacological compounds, our focus as a company is on promising research on two unique molecular compounds, JUVA-019 and JUVA-041. We continue to focus. “
Once all construction is complete, the number of cannabis flower growing rooms will double from 3 to 6 and the facility’s current system will be maximized without increasing costs. The final cost of construction was about $ 2.6 million, while the total cost of building the facility was about $ 12.5 million.
Juva successfully harvested nine times in 2021, and the team plans to harvest 33 times in 2022, with an average yield of £ 1.5 per light and a target of £ 2-2.5 per light. Currently, the flower room has 588 lights and the plant room has 196 lights.
In addition, we will be hosting a Live Zoom Webinar on March 23rd at 4pm EST to showcase the latest information and progress in Juva’s construction and to provide you with the latest information on the cannabis and pharmaceutical business. If you are interested in watching the webinar, you can attend the live concert or watch the recording on the Juva website immediately after the broadcast.
To register to participate in the webinar, please visit: https://us02web.zoom.us/webinar/register/WN_rDchFYF1QI6FovTi4uwOdw
On behalf of the board
Doug Chloupek, CEO and Founder
Juba Life Co., Ltd.
About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)
Juva Life employs cutting-edge science to discover, develop and commercialize safe and effective wellness and medicines in both the cannabis consumer segment and the non-cannabinoid-based healthcare industry. The company has successfully followed the 2018 roadmap, starting with standardization of cultivation, extraction and formulation to provide consumers with reproducible benefits. Juva is built on the chemistry skills of these natural product processes and now includes discovery pharmacology. We leverage the revenue generated from our retail business to leverage the Juva-019 and Juva-041 consumer and clinical development efforts, as well as other potentially valuable consumer and pharmaceutical applications. Promotes non-cannabinoid bioactive substances. Juva is working to bring the cannabis market to the next generation investment grade business model in this sector. See below for more information. https://juvalife.com/..
For more information, please contact:
Juba Life Investor Relations
Tel: Tel: +1 833-333-5882 (JUVA)
Description of future prospects
This news release contains statements and information that may constitute “forward-looking information” in the sense of applicable securities law, unless it is a historical fact. Forward-looking information may include statements about financial and other forecasts, as well as future plans, objectives, or financial performance, or the assumptions underlying any of the above. In some cases, forward-looking statements may be “may,” “do,” “can,” “do,” “probably,” “exception,” “anticipate,” “believe,” and “. It can be identified by terms such as “intended”. , “Plan”, “Forecast”, “Project”, “Estimate”, “Forecast”, or their negative expressions, or other similar expressions for matters that are not historical facts. Examples of such statements include, but are not limited to, statements regarding our objectives and business plans. Product development, commercialization strategies and future collaboration.
Forward-looking information includes known and unknown risks, uncertainties, and future results, performance, or performance that express or imply our actual results, performance, or performance by the information about the future. Includes other factors that may differ significantly from. Risks associated with our future business plans. The risk that we will not be able to retain key personnel. Described in the discussions and analysis of our management for the fiscal year ended December 31, 2020 under the heading “Risks and Uncertainties”, as well as the risks that we cannot secure under reasonable conditions or at all. All other risks that have been. Therefore, readers should not place excessive reliance on such forward-looking information. In addition, forward-looking information is provided only as of the date on which such statements were made. New factors emerge from time to time, and our management anticipates all of such factors and proactively assesses the impact of each such factor on our business, or any factor, or a combination of factors. That is impossible. , Actual results may differ materially from those contained in the forward-looking information. Unless required by law, including securities law, we provide forward-looking information to reflect information or events after the date it was created, or to reflect the occurrence of an unexpected event. We do not undertake any obligation to renew.
CSE is not responsible for the validity or accuracy of this release.
CBJ News Maker
Juba Life Announces Completion of Cannabis Cultivation Facility, Double Harvesting Capacity, Canadian Business Journal, Stockton, CA
Source link Juba Life Announces Completion of Cannabis Cultivation Facility, Double Harvesting Capacity, Canadian Business Journal, Stockton, CA